Formulation Design of Lipid Nanoparticles for Pharmaceutical Applications
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Physical Pharmacy and Formulation".
Deadline for manuscript submissions: 30 June 2025 | Viewed by 1767
Special Issue Editors
Interests: nanomedicine; drug formulation; pharmacy and pharmaceutical science
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Designing therapeutic payloads to deliver drug molecules to the targeted site is challenging, and lipid nanoparticles have gained substantial interest in preclinical and clinical studies, leveraging their potential outcomes in drug delivery over the last decades. Despite the few commercial successes of lipid nanoparticle technology in vaccines and drug therapeutics, their design, development and quality control studies in large-scale manufacturing have remained both complex and quandary due to a lack of robust and scalable synthesis techniques. It is crucial to understand the role of lipids in drug-loaded nanoparticle stability, bioavailability, safety and efficacy. This Special Issue aims to focus on the different types of lipids as delivery vectors and rationalize the current strategy of nanoparticle design and breakthroughs in their research. In this Special Issue, original research articles and reviews are welcome.
We look forward to receiving your contributions.
Prof. Dr. Shyamal Das
Dr. Mahbub Hassan
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- lipid nanoparticles
- drug delivery
- formulation
- stability
- controlled release
- regulatory challenges
- quality control
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
